Related Experiment Video
Updated: Mar 19, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
[Challenges for and potential approaches to deprescribing]
Carina Lundby1,2, Jesper Ryg3,4,5, Anton Pottegård1,2
1Sygehusapotek Fyn, Odense Universitetshospital.
Abstract:
Deprescribing is often challenged by differing attitudes of patients, relatives, and healthcare professionals. Such attitudes are summarised in this review. Patients may hold conflicting views, relatives influence decisions, and healthcare professionals face barriers such as a lack of guidance, uncertainty about benefits and harm, and resource constraints. Increasing awareness of these perspectives and integrating structured tools, clear guidance, and patient involvement in the deprescribing process can support shared decision-making and improve clinical practice and patient outcomes.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Related Concept Videos
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Desensitization and Tachyphylaxis